Cargando…

Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients

PURPOSE: Triple negative breast cancer (TNBC) accounts for approximately 15% of breast cancer cases and is associated with a poor prognosis. In this retrospective study of patients undergoing radiation therapy as part of their treatment, disease-free survival (DFS) and overall survival (OS) of TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Shelly, Manuel, Lucy, Doolan, Moira, Westhuyzen, Justin, Shakespeare, Thomas P, Aherne, Noel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064282/ https://www.ncbi.nlm.nih.gov/pubmed/32184654 http://dx.doi.org/10.2147/BCTT.S236483

Ejemplares similares

Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia
por: Hallenstein, Lucie G., et al.
Publicado: (2021)

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
por: Dubrava, Alex L, et al.
Publicado: (2023)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

Patterns of relapse following hippocampal avoidance prophylactic cranial irradiation for small cell lung carcinoma
por: Cook, Theresa A., et al.
Publicado: (2021)

Racial and Ethnic Inequality in Survival Outcomes of Women With Triple Negative Breast Cancer
por: Makhani, Sarah S, et al.
Publicado: (2022)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer
por: Zhao, Kangrong, et al.
Publicado: (2021)

Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
por: Shakespeare, Thomas P, et al.
Publicado: (2016)

Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
por: Shakespeare, Thomas P, et al.
Publicado: (2016)

Clinical Outcomes and Prognostic Factors In Triple-Negative Invasive Lobular Carcinoma of the Breast
por: Joshi, Utsav, et al.
Publicado: (2023)

Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US
por: Elimimian, Elizabeth B., et al.
Publicado: (2021)

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer
por: Chen, Hao, et al.
Publicado: (2020)

The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy
por: Fu, Wen-Fen, et al.
Publicado: (2020)

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
por: Urru, Silvana Anna Maria, et al.
Publicado: (2018)

Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer
por: Kuhar, Cvetka Grašič, et al.
Publicado: (2023)

Outcomes of Immediate Breast Reconstruction in Triple Negative Breast Cancer
por: Grigor, Emma, et al.
Publicado: (2021)

Survival Outcome and Impact of Chemotherapy in T1 Node-Negative Triple-Negative Breast Cancer: A SEER Database Analysis
por: Zhang, Jingyi, et al.
Publicado: (2020)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
por: Prat, A, et al.
Publicado: (2014)

Impact of radiation therapy on survival in patients with triple-negative breast cancer
por: STEWARD, LAUREN T., et al.
Publicado: (2014)

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

Overall survival of triple negative breast cancer in French Caribbean women
por: Beaubrun-Renard, Murielle Murielle, et al.
Publicado: (2022)

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
por: Ransohoff, Julia D., et al.
Publicado: (2023)

Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer
por: Yoen, Heera, et al.
Publicado: (2023)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival
por: Choi, Yoon-La, et al.
Publicado: (2010)

Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review
por: Starlard-Davenport, Athena, et al.
Publicado: (2013)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Does Race Affect Outcomes in Triple Negative Breast Cancer?
por: Sachdev, Jasgit C., et al.
Publicado: (2010)

Impact of Statin Use on Outcomes in Triple Negative Breast Cancer
por: Shaitelman, Simona F., et al.
Publicado: (2017)

The treatment and survival of patients with triple negative breast cancer in a London population
por: Pal, Shrestha, et al.
Publicado: (2014)

SPHK1 regulates proliferation and survival responses in triple-negative breast cancer
por: Datta, Arpita, et al.
Publicado: (2014)

Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells
por: Badana, Anil, et al.
Publicado: (2016)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells
por: Bassey-Archibong, Blessing I, et al.
Publicado: (2017)

WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer
por: Ertay, Ayse, et al.
Publicado: (2020)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtsnt31he7n009i0hv7du8t8ft